» Articles » PMID: 21784853

Distinct Involvement of the Gab1 and Grb2 Adaptor Proteins in Signal Transduction by the Related Receptor Tyrosine Kinases RON and MET

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Jul 26
PMID 21784853
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Although the signal transduction mechanisms of the receptor tyrosine kinase MET are well defined, less is known about its close relative RON. MET initiates intracellular signaling by autophosphorylation on specific cytoplasmic tyrosines that form docking sites for the adaptor proteins Grb2 and Gab1. Grb2 binds directly and is essential for all of the biological activities of MET. Gab1 docks either directly or indirectly via Grb2 and controls only a subset of MET functions. Because MET and RON possess similar adaptor binding sites, it was anticipated that their adaptor interactions would be conserved. Here we show that in contrast to MET, RON relies primarily on Gab1 for signal transmission. Surprisingly, disruption of the Grb2 docking site of RON or Grb2 depletion augments activity, whereas enhancement of Grb2 binding attenuates Gab1 recruitment and signaling. Hence, RON and MET differ in their adaptor interactions; furthermore, Grb2 performs a novel antagonistic role in the context of RON signaling.

Citing Articles

EGFR transactivates RON to drive oncogenic crosstalk.

Franco Nitta C, Green E, Jhamba E, Keth J, Ortiz-Caraveo I, Grattan R Elife. 2021; 10.

PMID: 34821550 PMC: 8654365. DOI: 10.7554/eLife.63678.


RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer.

Weng T, Yao M, Xu X, Hu C, Yao S, Liu Y Cancer Res Treat. 2020; 52(3):973-986.

PMID: 32324988 PMC: 7373856. DOI: 10.4143/crt.2019.726.


Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.

Allen J, Zhang J, Quickel M, Kennett M, Patterson A, Hankey-Giblin P J Proteome Res. 2018; 17(9):3268-3280.

PMID: 30091925 PMC: 6563938. DOI: 10.1021/acs.jproteome.8b00379.


Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.

Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C Mol Cancer. 2018; 17(1):45.

PMID: 29455668 PMC: 5817860. DOI: 10.1186/s12943-018-0796-y.


Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes.

Glasbey J, Sanders A, Bosanquet D, Ruge F, Harding K, Jiang W Biomedicines. 2017; 3(1):110-123.

PMID: 28536402 PMC: 5344237. DOI: 10.3390/biomedicines3010110.


References
1.
Schaeper U, Vogel R, Chmielowiec J, Huelsken J, Rosario M, Birchmeier W . Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo. Proc Natl Acad Sci U S A. 2007; 104(39):15376-81. PMC: 2000540. DOI: 10.1073/pnas.0702555104. View

2.
Matsumura I, Mizuki M, Kanakura Y . Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies. Cancer Sci. 2008; 99(3):479-85. PMC: 11158847. DOI: 10.1111/j.1349-7006.2007.00717.x. View

3.
Fixman E, Naujokas M, Rodrigues G, Moran M, Park M . Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. Oncogene. 1995; 10(2):237-49. View

4.
Bardelli A, Longati P, Gramaglia D, Stella M, Comoglio P . Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential. Oncogene. 1998; 15(25):3103-11. DOI: 10.1038/sj.onc.1201561. View

5.
Lahiry P, Torkamani A, Schork N, Hegele R . Kinase mutations in human disease: interpreting genotype-phenotype relationships. Nat Rev Genet. 2009; 11(1):60-74. DOI: 10.1038/nrg2707. View